NCT00467792

Brief Summary

The purpose of this study is to determine how long the skin lesions usually last and what kind of symptoms and signs children with urticaria pigmentosa may develop over the years. This information will allow physicians to better care for patients who have been diagnosed with this disease and to provide their parents with more complete information regarding what to expect for the future of their child. This research is being done because many unanswered questions remain regarding children with urticaria pigmentosa and its course.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 1, 2007

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

December 8, 2008

Status Verified

December 1, 2008

Enrollment Period

2.4 years

First QC Date

April 30, 2007

Last Update Submit

December 5, 2008

Conditions

Urticaria Pigmentosa

Keywords

urticaria pigmentosamastocytosismastocytomas

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study involves children, of age 0-18 years old who are diagnosed with urticaria pigmentosa during their visit at the Pediatric Dermatology Clinic.

You may qualify if:

  • Age 0-18 years old at diagnosis of UP
  • or more mastocytomas (diagnosis can be based on clinical exam; biopsy only necessary if diagnosis is in question)
  • patients recruited from Children's Hospital of Wisconsin Dermatology Clinic

You may not qualify if:

  • Less than 3 mastocytomas
  • Diffuse mastocytosis
  • TMEP
  • residence is out of Wisconsin/Illinois area or the United States

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Urticaria PigmentosaMastocytosis

Condition Hierarchy (Ancestors)

Mastocytosis, CutaneousNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsSkin NeoplasmsNeoplasms by SitePigmentation DisordersSkin DiseasesSkin and Connective Tissue DiseasesMast Cell Activation DisordersImmune System Diseases

Study Officials

  • Sheila Galbraith, MD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 30, 2007

First Posted

May 1, 2007

Study Start

January 1, 2006

Primary Completion

June 1, 2008

Study Completion

June 1, 2008

Last Updated

December 8, 2008

Record last verified: 2008-12

Locations

US(1)